Johns Hopkins University School of Medicine
733 N. Broadway
282 articles with Johns Hopkins University School of Medicine
Researchers at John Hopkins made their preliminary conclusions that the vaccines produced by Pfizer-BioNTech and Moderna did not cause the hearing loss.
Sysmex Inostics Presents Data at AACR Demonstrating SafeSEQ NGS Liquid Biopsy Delivers Equivalent Performance to the Extensively Clinically Validated OncoBEAM dPCR Technology for NSCLC Patients
Sysmex Inostics, Inc., a global leader of the liquid biopsy revolution for oncology, is presenting the poster "Clinical evaluation of NGS-based liquid biopsy testing in non-small cell lung cancer patients" at the 112th Annual Meeting of the American Association for Cancer Research on April 10, 2021, from 8:30 AM - 11:59 PM Eastern Daylight Time.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 20, 2020.
With billions of doses of COVID-19 vaccines expected to be available by year’s end, and a global population of 7.8 billion, public health officials are scrambling to deliver the vaccines in ways that are equitable and effective.
Women's Gynecologic Health and Obstetrical Care, Fetal Medicine, COPD and Lung Transplantation, Among Services That Will Benefit Western Pennsylvania Patients
Emulate Publishes Results for Intestine-Chip Populated with Organoids; Data Demonstrates Superior Human-relevant Intestine Function than Organoids Alone
Emulate’s Duodenum Intestine-Chip provides a robust system for preclinical drug assessment of drug transport, metabolism, and drug-drug interactions in the intestine
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Bloomberg Philanthropies, Johns Hopkins University School of Medicine, and The New York Stem Cell Foundation Research Institute Announce an Unprecedented Effort to Advance Precision Medicine
Unmatched Scope of Resources Will Identify Distinctive Disease Mechanisms in Small Patient Subgroups, Supporting Development of Custom Therapeutic Approaches [22-October-2019] NEW YORK , Oct. 22, 2019 /PRNewswire/ -- Bloomberg Philanthropies, Johns Hopkins University School of Medicine (JHUSOM), and The New York Stem Cell Foundation (NYSCF) Research Institute today
LUNGevity expands its Scientific Advisory Board with two Career Development Awardees to deepen expertise in areas key to LUNGevity's research program
World’s-First Ultra-High Resolution CT System Delivers Twice the Resolution of Today’s CT Systems
December 21 Research Roundup: HIV Vaccine, Super-Accurate Cervical Cancer Test, Molecular Mechani...
12/21/2018There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Many of these directors do not publicly disclose their affiliation with the pharma companies in their nonprofit biographies, report shows.
The extremely strong growth at the beginning of the year continued during the second quarter: sales surged 48 percent compared with the previous year and totaled SEK 8.6 million (5.8).
Streamlining product categories, standardization fuel non-clinical cost savings
Here’s a roundup of biopharma companies that have announced hiring trends since the beginning of the year.
The product is soon to meet clients in both the US and China.
The researchers took blood samples from 1,005 people with one of the eight different cancer types.
Immunomic Therapeutics Welcomes Key Thought Leader in Immuno-Oncology, Dr. Drew Pardoll, to Its Scientific Advisory Board
Dr. Pardoll is a world-renowned cancer researcher in the field of immuno-oncology.
Bonnie J. Addario Lung Cancer Foundation and International Association for the Study of Lung Cancer Award Johns Hopkins School of Medicine Researcher $300,000
The Bonnie J. Addario Lung Cancer Foundation (ALCF) and the International Association for the Study of Lung Cancer (IASLC) today announced the winner of the $300,000 ALCF-IASLC Second Joint International Fellowship Award for The Early Detection of Lung Cancer.
Antiretroviral Therapy May Lead To Syphilis In HIV-Positive Men, Johns Hopkins University School of Medicine Study